Cite
HARVARD Citation
Yoshinaga, K. et al. (2020). Low‐dose rituximab induction therapy is effective in immunological high‐risk renal transplantation without increasing cytomegalovirus infection. International journal of urology. pp. 1136-1142. [Online].